Bridging Canada’s life sciences gap: from world-class research to sovereign anchor companies
Government has an urgent opportunity to act so Canadian innovations can reach Canadian patients.
Canada doesn’t have an ideas problem; we have an adoption problem. Our researchers are producing world-class health innovations, but fragmented reimbursement, weak procurement pathways, limited late-stage capital, and IP leakage too often push promising firms, talent, and ...
SPONSORED CONTENT
Get Tuesdays: Innovation & Industry Newsletter
The policies, decisions, and people working on investment and regulation in the industry and innovation realm.
By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy
